Hence, we screened a panel of cells lines representing renal cancer (CAKI‐1, CAKI‐2, ACHN), bladder cancer (UC13, T24), and glioblastoma (U87MG), for expression of SEMA3C, EGFR, MET, Plexin B1, Plexin D1, NRP1, and NRP2 (Appendix Fig S2E). The gene discussed is MET; the disease is urinary bladder carcinoma.